Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study)
Yoon, Sun A., Han, Byoung G., Kim, Sung G., Han, Sang Y., Jo, Young I., Jeong, Kyung H., Oh, Kook H., Park, Hyeong C., Park, Sun H., Kang, Shin W., Na, Ki R., Kang, Sun W., Kim, Nam H., Jang, Young H.Volume:
19
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12863
Date:
April, 2017
File:
PDF, 919 KB
english, 2017
File converter
More search results
More benefits 
